|
MT-125 Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Phoenix, Arizona1 trial
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Mayo Clinic Hospital
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.